Eric J. Hyllengren, SVP, CFO at Atara Biotherapeutics, Inc. (ATRA), sold 8,186 shares at $1.65 ($14K) on 2023-08-16, disclosed to the SEC on 2023-08-18.
Open-market sale of $14k ATRA by SVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 1,778 | $3K | 21.7% |
| 2 | $1.65 | 6,408 | $11K | 78.3% |
| Total | $1.65 avg | 8,186 | $14K | 100% |
| Filing → |
| ATRA | SELL | 2024-08-20 | $7K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $18K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $5K | — | Filing → |